A5003027916- Cancer Genomics and Diagnostics
- Genetic factors in colorectal cancer
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genomics and Rare Diseases
- Innovations in Medical Education
- Music Therapy and Health
- Acute Lymphoblastic Leukemia research
- Empathy and Medical Education
University of Washington
2022
Fred Hutch Cancer Center
2022
University of Washington Medical Center
2022
University of Michigan
2019-2020
VA Ann Arbor Healthcare System
2020
Michigan United
2019
Acute myeloid leukemia (AML) has an aggressive course and a historically dismal prognosis. For many patients, hematopoietic stem cell transplantation (HSCT) represents the best option for cure, but access, utilization, health inequities on global scale remain poorly elucidated. We wanted to describe patterns of HSCT use in AML better understanding practices, unmet needs internationally. Estimates incident cases 2016 were obtained from Global Burden Disease 2019 study. activities collected...
Abstract Background Arts exposure is associated with positive psychological constructs. To date, no randomized, controlled studies have integrated art into clinical medical education or measured its effects on constructs educational outcomes. In this study, we assessed the possibility and potential benefits of integrating visual arts a required internal medicine (IM) clerkship. Methods We conducted trial in an academic healthcare system affiliated museum. IM students were assigned to one...
Successful treatment of relapsed/refractory and rare subtypes lymphomas remains a therapeutic challenge. Though the use tumor profiling is increasing, little described about how providers ultimately utilize this information in clinical decision-making. We reviewed 92 adult lymphoma patients who underwent an IRB-approved sequencing protocol at University Michigan, MI-ONCOSEQ. Of cohort, 60 had targeted suggested by their test results, 11 MI-ONCOSEQ recommended therapy. One obtained complete...
e14645 Background: Despite the increasing availability of targeted and novel therapies, successful treatment many relapsed/refractory lymphomas remains a challenge. Tumor sequencing is becoming an increasingly available technique to identify potential therapeutic targets; however, there considerable uncertainty about application this data in “real world” clinical setting. Methods: Herein, we describe 91 lymphoma patients who underwent DNA & RNA tumor biopsies via MIONCOSEQ protocol...